Related Experiment Video
Updated: Sep 30, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Acute management of atrial fibrillation: Part I. Rate and rhythm control
Dana E King1, Lori M Dickerson, Jonathan L Sack
1Department of Family Medicine at the Medical University of South Carolina, Charleston 29425, USA. kingde@musc.edu
Insights
Atrial fibrillation (AF) management focuses on rate control using medications like beta-blockers. Cardioversion may be needed to restore normal rhythm, requiring anticoagulation with heparin and warfarin to prevent serious complications.
Area of Science:
- Cardiology
- Internal Medicine
- Family Practice
Background:
- Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care settings.
- Serious AF complications include heart failure, myocardial infarction, and thromboembolism.
- Effective management is crucial to prevent adverse outcomes.
Purpose of the Study:
- To outline current treatment guidelines for atrial fibrillation.
- To provide a framework for managing ventricular rate and restoring sinus rhythm.
- To emphasize the importance of anticoagulation in AF management.
Main Methods:
- Review of current clinical guidelines from major cardiovascular organizations.
- Summarization of evidence-based strategies for rate control and rhythm restoration.
- Integration of recommendations for anticoagulation therapy.
Main Results:
- Initial management prioritizes ventricular rate control, often with calcium channel blockers, beta-blockers, or digoxin.
- Cardioversion (medical or electrical) is indicated for persistent AF.
- Anticoagulation with heparin and warfarin is essential before and after cardioversion.
Conclusions:
- Current guidelines recommend a stepwise approach to AF management.
- Rate control is the primary initial treatment, followed by rhythm restoration if necessary.
- Appropriate anticoagulation is critical for preventing thromboembolic events in AF patients.
Abstract:
Atrial fibrillation is the arrhythmia most commonly encountered in family practice. Serious complications can include congestive heart failure, myocardial infarction, and thromboembolism. Initial treatment is directed at controlling the ventricular rate, most often with a calcium channel blocker, a beta blocker, or digoxin. Medical or electrical cardioversion to restore sinus rhythm is the next step in patients who remain in atrial fibrillation. Heparin should be administered to hospitalized patients undergoing medical or electrical cardioversion. Anticoagulation with warfarin should be used for three weeks before elective cardioversion and continued for four weeks after cardioversion. The recommendations provided in this two-part article are consistent with guidelines published by the American Heart Association and the Agency for Healthcare Research and Quality.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

